
Timber Pharmaceuticals, Inc. (AMEX:TMBR) Appoints Alan Mendelsohn, M.D., as Chief Medical Officer
On 01-28-2k21 (Thursday) Shareholders tracking shares of Timber Pharmaceuticals, Inc. (TMBR) belongs to Healthcare sector and Biotechnology industry. TMBR flaunted -12.93% to reach at $1.28 during previous trading session. TMBR …
Read More